2. Organization and Business

Business Summary

The Company is a regenerative medicine company with a portfolio of proprietary products and technologies for peripheral nerve reconstruction and regeneration. Peripheral nerves provide the pathways for both motor and sensory signals throughout the body and their damage can result in the loss of function and feeling. In order to improve surgical reconstruction and regeneration of peripheral nerves, the Company has developed and licensed technologies which are used in its products. Its product portfolio includes Avance^® Nerve Graft, which the Company believes is the only commercially available allograft nerve for bridging nerve discontinuities (a gap created when the nerve is severed), AxoGuard ^® Nerve Connector, a coaptation aid allowing for close approximation of severed nerves, and AxoGuard ^® Nerve Protector that protects nerves during the body’s healing process after surgery.